Key result
Saralasin administration lowered blood pressure from 191/112 to 147/85 mm Hg in a subset of responder patients on chronic hemodialysis.
Why the study?
Does saralasin lower blood pressure in hypertensive patients on chronic hemodialysis?
Does saralasin lower blood pressure in hypertensive patients on chronic hemodialysis?
Saralasin administration identifies renin-dependent hypertension in chronic hemodialysis patients by significantly lowering blood pressure in responders.
Answers are grounded in this paper and cite their sources.
May identify renin-dependent hypertension in select hemodialysis patients; leaves open need for prospective trials before clinical adoption.
Hypertension in patients on chronic hemodialysis is thought to be largely of two types--volume dependent or renin dependent. If renin-dependent hypertension is mediated by angiotensin II, then angiotensin II antagonism should lower blood pressure. To test this hypothesis, the angiotensin II antagonist saralasin was given to 15 hypertensive patients on chronic hemodialysis. Patients were separated into two groups by their blood pressure response. In responders blood pressure was 191/112 mm Hg and fell to 147/85 during saralasin administration (P less than 0.01). In contrast, nonresponders had blood pressures of 190/111 mm Hg before and 188/110 during saralasin administration. Five responders subsequently ahd nephrectomies with normalization of their blood pressures. Plasma renin activity averaged 70 ng/ml . 3 h of angiotensin I in responders and increased to 110 after saralasin (P less than 0.05), while nonresponders had values of 21 before and after saralasin. These results offer strong support for the hypothesis that renin-dependent hypertension is an important mechanism in certain patients on chronic hemodialysis and that such patients will respond to angiotensin II antagonism.
No takes yet. Share an insight, caveat, or question.
Lifschitz et al. (1978) studied Hypertension on chronic hemodialysis (n=15). Saralasin was evaluated on Blood pressure (p=<0.01). Saralasin administration lowered blood pressure from 191/112 to 147/85 mm Hg in a subset of responder patients on chronic hemodialysis.
Synapse has enriched 10 related papers. Consider them for comparative context: